FibroBiologics, Inc. Common Stock (FBLG) Investor Relations Documents

FibroBiologics, Inc. Common Stock (FBLG) investor relations documents from the company's IR site: 25 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-11Press releaseFibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insu
2026-08-05Press releaseFibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage
2026-07-31Press releaseFibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candi
2026-07-09Press releaseFibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors
2026-07-07Press releaseFibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical
2026-06-30Press releaseFibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
2026-06-29Press releaseFibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
2026-06-26Press releaseFibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
2026-06-22Press releaseFibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Heali
2026-06-16Press releaseFibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers
2026-06-03Press releaseFibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabet
2026-05-22Press releaseDownload as PDF
2026-05-18Press releaseFibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics
2026-05-18Press releaseDownload as PDF
2026-04-30Press releasePDF
2026-02-24Press releasePDF
2025-10-31Press releasePDF
2025-07-31Press releasePDF
2025-05-14Press releasePDF
2025-03-31Press releasePDF
2025-03-31Press releaseEarnings Release
2024-11-12Press releaseEarnings Release
2024-11-12Press releasePDF
2024-11-12Press releaseFibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
2024-08-07Press releaseFibroBiologics Files 2024 Second Quarter Report

FBLG overview · FBLG earnings · FBLG financials · FBLG KPIs · FBLG ownership · FBLG peers · FBLG filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.